Evaluation of the quick diagnosis and treatment program for lung cancer

被引:1
作者
Granell, E. [1 ]
Hidalgo, A. [1 ]
Martinez, A. [1 ]
Gich, I. [2 ]
Bolivar, I. [2 ]
Franquet, T. [1 ]
Gimenez, A. [1 ]
Alepuz, T. [2 ]
机构
[1] Hosp Santa Creu & Sant Pau, Serv Radiodiagnost, Barcelona, Spain
[2] Hosp La Santa Creu & Sant Pau, Serv Epidemiol, Barcelona, Spain
来源
RADIOLOGIA | 2009年 / 51卷 / 03期
关键词
Lung cancer; Quick diagnosis; Quick treatment; Prognosis;
D O I
10.1016/j.rx.2008.10.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To analyze the efficiency of the program of quick diagnosis and treatment (PDTR, programa de diagnostico y tratamiento rapido) of lung cancer established in the Hospital de la Santa Creu i Sant Pau of Barcelona to review the epidemiology of lung cancer. Methods and materials: Fifty-eight patients with lung cancer were studied. Twenty-nine of them were included in the program between October 2005 and May 2006, and the remaining were randomly selected among those diagnosed the year before (control group). Time between first visit, diagnosis and treatment and other variables (age, sex, histological type and TNM stage) were compared between groups. Results: Significant differences were found between the two groups. PDTR patients had a mean time between first visit and treatment of 26.7 days (Standard Deviation [SD] = 13.6), whereas this was 84 days (SD = 53) in the control group. The PDTR group had a lower TNM stage, but statistical significance was only found in N (lymph node involvement) (p = 0.007). Conclusion: Most patients included in the PDTR program spend less than 30 days between first visit and treatment, which represents a significant reduction in time (p <0.001). The effect on prognosis is controversial and will need long term studies. (C) 2007 SERAM. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 50 条
  • [31] Preoperative evaluation in surgical treatment of lung cancer
    Inci, Ilhan
    Pabuscu, Engin
    [J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2005, 53 (02): : 210 - 220
  • [32] Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer
    Maly, Vilem
    Maly, Ondrej
    Kolostova, Katarina
    Bobek, Vladimir
    [J]. IN VIVO, 2019, 33 (04): : 1027 - 1037
  • [33] Early-stage lung cancer: Diagnosis and treatment
    Ohira T.
    Suga Y.
    Nagatsuka Y.
    Usuda J.
    Tsuboi M.
    Hirano T.
    Ikeda N.
    Kato H.
    [J]. International Journal of Clinical Oncology, 2006, 11 (1) : 9 - 12
  • [34] Diagnosis and treatment of lung cancer - Non-small cell lung cancer, small cell lung cancer and carcinoids
    End A.
    [J]. European Surgery, 2006, 38 (1) : 45 - 53
  • [35] The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
    Fang, Rui
    Zhu, Yong
    Khadka, Vedbar S.
    Zhang, Fan
    Jiang, Bin
    Deng, Youping
    [J]. FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [36] Evaluation of delays during diagnosis and management of lung cancer in India: A prospective observational study
    Garg, Avneet
    Iyer, Hariharan
    Jindal, Vinita
    Vashistha, Vishal
    Chawla, Gopal
    Tiwari, Pawan
    Mittal, Saurabh
    Madan, Karan
    Hadda, Vijay
    Guleria, Randeep
    Sati, Hem C.
    Mohan, Anant
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (05)
  • [37] MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment
    Zhao, Qian
    Li, Ping
    Ma, Junrong
    Yu, Xijie
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2015, 10 (02) : 182 - 200
  • [38] Diagnosis status and pathological diagnosis derived treatment of elderly lung cancer patients over 75 years old
    Wu, Guannan
    Gu, Xiaoling
    Yuan, Dongmei
    Yao, Yanwen
    Yang, Wen
    Lv, Tangfeng
    Song, Yong
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 87 - 95
  • [39] MicroRNAs in diagnosis and prognosis in lung cancer
    Avila-Moreno, Federico
    Urrea, Francisco
    Ortiz-Quintero, Blanca
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (05): : 516 - 535
  • [40] Circulating microRNAs in lung cancer: Prospects for diagnosis, prognosis, and prediction of antitumor treatment efficacy
    V. V. Vlassov
    E. Yu. Rykova
    A. A. Ponomaryova
    I. A. Zaporozhchenko
    E. S. Morozkin
    N. V. Cherdyntseva
    P. P. Laktionov
    [J]. Molecular Biology, 2015, 49 : 48 - 57